Advertisement

The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia

      Abstract

      Objective

      The objective of this study was to evaluate the association of elevated alveolar-arterial oxygen (A-a O2) gradient with risk of mortality in hospitalized patients with community-acquired pneumonia (CAP).

      Methods

      This prospective study included 206 patients diagnosed with CAP admitted to the ED. Demographics, comorbidities, arterial blood gas, serum electrolytes, liver-renal functions, complete blood count, NLR, PLR, CRP, CAR, procalcitonin, A-a O2 gradient, expected A-a O2 and A-a O2 difference were evaluated. PSI and CURB-65 scores were classified as follow: a) PSI low risk (I-III) and moderate-high risk (IV-V) groups; b) CURB-65; low risk (0–2) and high risk (3–5) groups.

      Results

      The survival rates of the PSI class (I-III) were significantly higher than the ones of the PSI class (IV-V) (92.1% vs. 62.9%, respectively). The percentage of survivors of the CURB-65 score (0–2) group (81.9%) was higher than the survivors of CURB-65 score (3–5) group (27.8%). Creatinine, BUN, uric acid, phosphorus, RDW, CRP, CAR, procalcitonin, lactate, A-a 02 gradient, expected A-a 02 and A-a 02 difference were significantly higher and basophil was lower in non-survivors. A-a O2 gradient (AUC 0.78), A-a O2 difference (AUC 0.74) and albumin (AUC 0.80) showed highest 30-day mortality prediction. NLR (AUC 0.58) and PLR (AUC 0.55) showed lowest 30-day mortality estimation. Procalcitonin (AUC 0.65), PSI class (AUC 0.81) and PSI score (AUC 0.86) indicated statistically significant higher 30-day mortality prediction.

      Conclusion

      A-a O2 gradient, A-a O2 difference and albumin are potent predictors of 30-day mortality in CAP patients in the ED.

      Keywords

      To read this article in full you will need to make a payment
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shah B.A.
        • Ahmed W.
        • Dhobi G.N.
        • Shah N.N.
        • Khursheed S.Q.
        • Haq I.
        Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting.
        Indian J Chest Dis Allied Sci. 2010; 52: 9-17
        • Julián-Jiménez A.
        • de los Reyes MJ Palomo
        • Miguez R.P.
        • Laín-Terés N.
        • Cuena-Boy R.
        • Lozano-Ancín A.
        Improved management of community-acquired pneumonia in the emergency department.
        Arch Bronconeumol. 2013; 49: 230-240https://doi.org/10.1016/j.arbres.2012.12.008
        • Bulbul Y.
        Community-acquired pneumonia data in Turkey.
        Güncel Göğüs Hastalık Seri. 2014; 2: 1-10
        • de Jager C.P.
        • Wever P.C.
        • Gemen E.F.
        • Kusters R.
        • van Gageldonk-Lafeber A.B.
        • van der Poll T.
        • et al.
        The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia.
        PLoS ONE. 2012; 7e46561https://doi.org/10.1371/journal.pone.0046561
        • Lee J.H.
        • Song S.
        • Yoon S.Y.
        • Lim C.S.
        • Song J.W.
        • Kim H.S.
        Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic markers for pneumonia severity.
        Br J Biomed Sci. 2016; 73: 140-142https://doi.org/10.1080/09674845.2016.1209898
        • Ranzani O.T.
        • Prina E.
        • Menendez R.
        • Ceccato A.
        • Cilloniz C.
        • Mendez R.
        • et al.
        New sepsis definition (Sepsis-3) and community-acquired pneumonia mortality. A validation and clinical decision-making study.
        Am J Respir Crit Care Med. 2015; 196: 1287-1297https://doi.org/10.1164/rccm.201611-2262OC
        • Nobre V.
        • Borges I.
        Prognostic value of procalcitonin in hospitalized patients with lower respiratory tract infections.
        Rev Bras Ter Intensiva. 2016; 28: 179-189https://doi.org/10.5935/0103-507X.20160019
        • Diehl J.L.
        • Mercat A.
        • Pesenti A.
        Understanding hypoxemia on ECCO2R: back to the alveolar gas equation.
        Intensive Care Med. 2019; 45: 255-256https://doi.org/10.1007/s00134-018-5409-0
        • Moammar M.Q.
        • Azam H.M.
        • Blamoun A.I.
        • Rashid A.O.
        • Ismail M.
        • Khan M.A.
        • et al.
        Alveolar–arterial oxygen gradient, pneumonia severity index and outcomes in patients hospitalized with community acquired pneumonia.
        Clin Exp Pharmacol P. 2008; 35: 1032-1037https://doi.org/10.1111/j.1440-1681.2008.04971
        • Shehata S.M.
        • Sileem A.E.
        • Shahien N.E.
        Prognostic values of pneumonia severity index, CURB-65 and expanded CURB-65 scores in community-acquired pneumonia in Zagazig University hospitals.
        Egypt J Chest Dis Tuberc. 2017; 66: 549-555https://doi.org/10.1016/j.ejcdt.2017.01.001
        • PSI/PORT Score
        Pneumonia severity index for CAP.
        https://www.mdcalc.com/a-a-o2-gradient
        Date accessed: November 2, 2018
        • Zhang Z.X.
        • Yong Y.
        • Tan W.C.
        • Shen L.
        • Seong H.
        • Fong K.Y.
        Prognostic factors for mortality due to pneumonia among adults from different age groups in Singapore and mortality predictions based on PSI and CURB-65.
        Singapore Med J. 2018; 59: 190-198https://doi.org/10.11622/smedj.2017079
        • Irfan M.
        • Hussain S.F.
        • Mapara K.
        • Memon S.
        • Mogri M.
        • Bana M.
        • et al.
        Community acquired pneumonia: risk factors associated with mortality in a tertiary care hospitalized patients.
        J Pak Med Assoc. 2009; 59: 448-452
        • Madhu S.
        • Augustine S.
        • Kumar R.
        • Kauser M.
        • Kumar V.
        • Jayaraju B.S.
        Comparative study of CURB-65, pneumonia severity index and IDSA/ATS scoring systems in community acquired pneumonia in an Indian tertiary care setting.
        Int J Adv Med. 2017; 4: 693-700https://doi.org/10.18203/2349-3933.ijam20172088
        • Alavi-Moghaddam M.
        • Bakhshi H.
        • Rezaei B.
        • Khashayar P.
        Pneumonia severity index compared to CURB-65 in predicting the outcome of community acquired pneumonia among patients referred to an Iranian emergency department: a prospective survey.
        Braz J Infect Dis. 2013; 17: 179-183https://doi.org/10.1016/j.bjid.2012
        • Damayanti N.
        • Abidin A.
        • Keliat E.N.
        The correlation between albumin levels with 30 days mortality in community acquired pneumonia patients.
        Earth Environ Sci. 2018; 125: e012141https://doi.org/10.1088/1755-1315/125/1/012141
        • Alsancak Y.
        • Sivri S.
        • Baştuğ S.
        • Bozkurt E.
        Role of calcium–albumin ratio in severity of coronary artery disease assessed by angiographic SYNTAX score.
        Arch Clin Exp Med. 2018; 3: 174-178https://doi.org/10.25000/acem.450950
        • Vincent J.L.
        • Dubois M.J.
        • Navickis R.J.
        • Wilkes M.M.
        Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials.
        Ann Surg. 2003; 237: 319-334https://doi.org/10.1097/01.SLA.0000055547.93484.87
        • Kuti B.P.
        • Adegoke S.A.
        • Ebruke B.E.
        • Howie S.
        • Oyelami O.A.
        • Ota M.
        Determinants of oxygen therapy in childhood pneumonia in a resource-constrained region.
        ISRN Pediatr. 2013; 2013: 435976https://doi.org/10.1155/2013/435976
        • Chou C.Y.
        • Wang S.M.
        • Liang C.C.
        • Chang C.T.
        • Liu J.H.
        • Wang I.K.
        • et al.
        Risk of pneumonia among patients with chronic kidney disease in outpatient and ınpatient settings. A nationwide population-based study.
        Medicine (Baltimore). 2014; 93: e174https://doi.org/10.1097/MD.0000000000000174
        • Zhu H.C.
        • Cao R.L.
        The relationship between serum levels of uric acid and prognosis of infection in critically ill patients.
        World J Emerg Med. 2012; 3: 186-190https://doi.org/10.5847/wjem.j.issn.1920-8642.2012.03.005
        • Gutierrez O.M.
        The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know.
        Adv Nutr. 2013; 4: 723-729https://doi.org/10.3945/an.113.004812
        • Bello S.
        • Fandos S.
        • Lasierra A.B.
        • Minchole E.
        • Panadero C.
        • Simon A.L.
        • et al.
        Red blood cell distribution width and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
        Respir Med. 2015; 109: 1193-1206https://doi.org/10.1016/j.rmed.2015.07.003
        • Schmidt de Oliveira-Netto A.C.
        • Morello L.G.
        • Dalla-Costa L.M.
        • Petterle R.R.
        • Fontana R.M.
        • Danieli Conte D.
        • et al.
        Procalcitonin, c-reactive protein, albumin, and blood cultures as early markers of sepsis diagnosis or predictors of outcome: a prospective analysis.
        Clin Pathol. 2019; 12 ([2632010X19847673])
        • Chen Y.X.
        • Li C.S.
        Lactate on emergency department arrival as a predictor of mortality and site-of-care in pneumonia patients: a cohort study.
        Thorax. 2015; 70: 404-410https://doi.org/10.1136/thoraxjnl-2014-206461
        • Isoda K.
        • Takeuchi T.
        • Kotani T.
        • Hata K.
        • Shoda T.
        • Ishida T.
        • et al.
        Pre-treatment ferritin level and alveolar-arterial oxygen gradient can predict mortality rate due to acute/subacute interstitial pneumonia in dermatomyositis treated by cyclosporine a/glucocorticosteroid combination therapy: a case control study.
        PLoS ONE. 2014; 9e89610https://doi.org/10.1371/journal.pone.0089610
        • Kartal O.
        • Kartal A.T.
        Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia.
        Bratisl Med J. 2017; 118: 513-516https://doi.org/10.4149/BLL_2017_099
        • Curbelo J.
        • Rajas O.
        • Arnalich B.
        • Galván-Román J.M.
        • Luquero-Bueno S.
        • Ortega-Gómez M.
        • et al.
        Neutrophil count percentage and neutrophil–lymphocyte ratio as prognostic markers in patients hospitalized for community-acquired pneumonia.
        Arch Bronconeumol. 2019; 55: 472-477https://doi.org/10.1016/j.arbres.2019.02.005
        • Pantzaris N.D.
        • Platanaki C.
        • Pierrako C.
        • Karamouzos V.
        • Velissaris D.
        Neutrophil-to-lymphocyte ratio relation to sepsis severity scores and inflammatory biomarkers in patients with community-acquired pneumonia: a case series.
        J Transl Int Med. 2018; 6: 43-46https://doi.org/10.2478/jtim-2018-0009
        • Dev S.P.
        • Hillmer M.D.
        • Ferri M.
        Arterial puncture for blood gas analysis.
        N Engl J Med. 2011; 364: e7https://doi.org/10.1056/NEJMvcm0803851
        • Kozacı N.
        • Gungor F.
        • Ay M.O.
        • Beydilli I.
        • Bozdemir N.
        • Akyol C.
        Can venous blood gas values be used instead of arterial blood gas values in respiratory alkalosis?.
        Turk J Biochem. 2014; 39: 113-118https://doi.org/10.5505/tjb.2014.87049